Krystal Biotech Inc

+1.06 (+1.38%)
4:09:31 PM EDT: $77.74 0.00 (0.00%)
Earnings Announcements

Krystal Biotech Reports Q3 Loss Per Share Of $1.17

Published: 11/07/2022 12:53 GMT
Krystal Biotech Inc (KRYS) - Krystal Biotech Announces Third Quarter 2022 Financial Results and Operational Highlights.
Krystal Biotech Inc - Strong Balance Sheet, Closing Quarter With $407.0 Million in Cash, Cash Equivalents and Investments.
Krystal Biotech Inc Qtrly Net Loss per Common Share: Basic and Diluted$1.17.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.01

Next Quarter Revenue Guidance is expected to be $26.6 Million
Next Quarter EPS Guidance is expected to be -$0.76

More details on our Analysts Page.